论文部分内容阅读
Model Based Drug Development for Combinatory Therapy to Treat Infection Caused by Resistant Pathogen
【机 构】
：
Senior Principal Scientist Senior Pharmacometrician AstraZeneca R&D in US,Wilmington,US
【出 处】
：
The 3rd International Symposium of Quantitative Pharmacology
【发表日期】
：
2011年12期
其他文献
How Exposure-Response and M&S Can Facilitate P3 Dose Selection at EOP2 for Oncology Protein Therapeu
会议
Model-Based Drug Development (MBDD) of Pegylated Growth Hormone (PEG-hGH) in the Treatment of Adults
会议
Modeling of Angiotensin ⅡAngiotensin-(1-7) counterbalance in disease progression of Spontaneously Hy
会议
Race Difference:Model*based pharmacodynamics of Rosuvastatin in western and Asian Hypercholesterolem
会议